RJA
PRTA icon

Raymond James & Associates’s Prothena Corp PRTA Stock Holding History

Raymond James & Associates’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,167
Closed -$297K – 4011
2023
Q4 		$297K Hold
8,167
– – ﹤0.01% 3283
2023
Q3 		$394K Buy
8,167
+4,050
+98% +$241K ﹤0.01% 3032
2023
Q2 		$281K Sell
4,117
-2,100
-34% -$135K ﹤0.01% 3296
2023
Q1 		$301K Buy
6,217
+1,212
+24% +$64K ﹤0.01% 3242
2022
Q4 		$302K Buy
+5,005
New +$293K ﹤0.01% 3212
2022
Q1 		– Sell
-4,700
Closed -$232K – 4244
2021
Q4 		$232K Hold
4,700
– – ﹤0.01% 3603
2021
Q3 		$335K Buy
4,700
+800
+21% +$49.7K ﹤0.01% 3339
2021
Q2 		$200K Buy
+3,900
New +$122K ﹤0.01% 3686
2018
Q4 		– Sell
-10,326
Closed -$135K – 3663
2018
Q3 		$135K Sell
10,326
-1,323
-11% -$19.1K ﹤0.01% 3392
2018
Q2 		$170K Buy
+11,649
New +$230K ﹤0.01% 3310

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Raymond James & Associates's PRTA Position: Q1 2024 in Review

Raymond James & Associates sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 8,167 shares — an estimated $297K sold.

Raymond James & Associates first reported a position in PRTA in Q2 2018 and held it in 10 quarters. The position peaked at $394K in Q3 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • Raymond James & Associates reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 8,167 Prothena Corp shares in Q1 2024, an estimated $297K.
  • Raymond James & Associates first reported a position in Prothena Corp in Q2 2018 and held it in 10 quarters.
  • Raymond James & Associates's Prothena Corp position peaked at $394K in Q3 2023.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.